Categories
Front Page News Pharmaceutical Sciences

Loesgen, Indra, et.al featured in the Daily Barometer

Dr. Sandra Loesgen and Dr. Arup Indra, members of the Graduate Program in Pharmaceutical Sciences, were interviewed for their collaborative work on treatments for melanoma.

Categories
Pharmaceutical Sciences publication

Sahay et.al publication announcement

Supramolecular self assembly of nanodrill-like structures for intracellular delivery. Ashwanikumar N1, Plaut JS2, Mostofian B3, Patel S1, Kwak P1, Sun C4, McPhail K1, Zuckerman DM3, Esener SC5, Sahay G6.

Categories
Pharmaceutical Sciences publication

Ishmael et.all publication announcement

Dr. Jane Ishmael and her lab, in collaboration with Dr. Kerry McPhail and Dr. Ian Ganley (University of Dundee, Scotland) announce the publication of a manuscript entitled “ATG5 Promotes Death Signaling in Response to the Cyclic Depsipeptides Coibamide A and Apratoxin A” in Marine Drugs, 2018 Mar 1;16(3). pii: E77. doi: 10.3390/md16030077

Categories
Front Page grant Mahmud Pharmaceutical Sciences

Mahmud et.al wins NSF grants to advance technologies for nontoxic sunscreen ingredients and improved indoor air quality.

Gadusol Laboratories of Corvallis, Ore., received a $225,000 Phase I SBIR grant to advance a technology for producing UV blocking compounds found in marine life that can be used in environmentally friendly, all-natural sunscreens. –Oregon Best

Categories
Front Page research Sikora

Sikora et al take key step toward gonorrhea vaccine

Research led by co-corresponding authors Aleksandra Sikora of Oregon State University and Nicholas Noinaj of Purdue University provides key structural and functional insights into a multicomponent protein complex known as BAM, short for beta-barrel assembly machinery. Featured in the news.

Categories
grant Pharmaceutical Sciences

Morgun, et al. Awarded Medical Research Foundation Grant

A Medical Research Foundation Grant in the amount of $40,000 in support of your project, “Host-microbiota interactions in a model of immunodeficiency-associated enteropathy,” has been approved for funding. Your award period is March 1, 2018, through February 28, 2019.